Clinical Trial: The xDAPT External Validation Study
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Coronary Artery Disease
Study Type: OBSERVATIONAL
Official Title: External Validation of an Individualized Patient Centered Machine Learning Model for the Prediction of Ischemic and Bleeding Risk in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary I
Brief Summary:
Dual antiplatelet therapy (DAPT) is routinely recommended after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation to prevent thrombotic complications.However, DAPT is also associated with an increased risk of bleeding, which may have a similar or even greater impact on prognosis compared to recurrent ischemic events.To balance these risks, individualized risk stratification at the time of PCI is crucial for determining the optimal DAPT composition and duration, aiming to reduce…
Read more